GOLDMAN SACHS GROUP INC - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 32 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$31,832,000
+31.6%
17,460,000
+74.6%
0.01%
+25.0%
Q3 2014$24,188,000
+20226.1%
10,000,000
+9900.0%
0.01%
Q2 2013$119,000100,0000.00%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
GRACE BROTHERS MANAGEMENT LLC 2,800,000$5,117,0004.90%
SILVERBACK ASSET MANAGEMENT LLC 18,209,000$33,322,0004.30%
RAVEN ROCK CAPITAL MANAGEMENT, LLC 1,000,000$1,990,0002.80%
Verition Fund Management LLC 5,504,000$10,062,0002.26%
CAMDEN ASSET MANAGEMENT L P /CA 26,798,000$48,856,0001.81%
GUARDIAN LIFE INSURANCE CO OF AMERICA 8,600,000$15,679,0001.60%
TENOR CAPITAL MANAGEMENT Co., L.P. 3,000,000$5,490,0001.46%
BASSO CAPITAL MANAGEMENT, L.P. 4,825,000$8,782,0001.40%
Wellesley Asset Management 12,564$23,006,0001.35%
WOLVERINE ASSET MANAGEMENT LLC 31,156,000$56,979,0001.11%
View complete list of SALIX PHARMACEUTICALS INC shareholders